We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
Cap. Flow
-$209M
Cap. Flow %
-30.05%
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257

Top Buys

Rank Stock Value
1
INFI
Infinity Pharmaceuticals, Inc.
INFI
+$2.36M
2
COLL icon
Collegium Pharmaceutical
COLL
+$2.32M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$2.29M
4
HSII
Heidrick & Struggles
HSII
+$2.25M
5
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
+$2.17M

Top Sells

Rank Stock Value
1
EBS icon
Emergent Biosolutions
EBS
+$5.99M
2
CMC icon
Commercial Metals
CMC
+$5.95M
3
BHE icon
Benchmark Electronics
BHE
+$5.84M
4
UPBD icon
Upbound Group
UPBD
+$5.71M
5
RAIL icon
FreightCar America
RAIL
+$5.51M

Sector Composition

Rank Sector Weight
1 Healthcare 18.04%
2 Industrials 15.17%
3 Technology 12.86%
4 Consumer Discretionary 12.11%
5 Financials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLX icon
351
Helix Energy Solutions
HLX
$1.42B
$715K 0.1%
+127,725
New +$539K
CMC icon
352
Commercial Metals
CMC
$7.53B
$714K 0.1%
42,077
-405,792
-91% -$5.95M
GCO icon
353
Genesco
GCO
$416M
$713K 0.1%
+9,868
New +$637K
TTPH
354
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$706K 0.1%
+7,625
New +$762K
NMIH icon
355
NMI Holdings
NMIH
$3.27B
$704K 0.1%
139,458
-11,166
-7% -$58.2K
PGND
356
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
$702K 0.1%
+23,344
New +$664K
SLM icon
357
SLM Corp
SLM
$4.78B
$701K 0.1%
110,225
+35,885
+48% +$217K
TCBK icon
358
TriCo Bancshares
TCBK
$1.84B
$701K 0.1%
+27,675
New +$701K
CHDN icon
359
Churchill Downs
CHDN
$6.15B
$690K 0.1%
+27,996
New +$640K
PLUS icon
360
ePlus
PLUS
$2.33B
$689K 0.1%
+34,244
New +$707K
DERM
361
DELISTED
Dermira, Inc.
DERM
$688K 0.1%
33,273
+19,889
+149% +$488K
IMDZ
362
DELISTED
Immune Design Corp.
IMDZ
$687K 0.1%
+52,818
New +$610K
VASC
363
DELISTED
Vascular Solutions Inc
VASC
$686K 0.1%
21,096
-10,210
-33% -$294K
SHOR
364
DELISTED
ShoreTel, Inc.
SHOR
$685K 0.1%
92,105
-279,198
-75% -$2.13M
XRM
365
DELISTED
Xerium Technologies Inc (new)
XRM
$682K 0.1%
130,580
+105,574
+422% +$859K
PRTK
366
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$681K 0.1%
+44,891
New +$687K
AHL
367
DELISTED
ASPEN Insurance Holding Limited
AHL
$674K 0.1%
+14,128
New +$645K
HAYN
368
DELISTED
Haynes International, Inc.
HAYN
$672K 0.1%
18,412
-12,710
-41% -$417K
HTB
369
HomeTrust Bancshares
HTB
$833M
$661K 0.1%
+36,066
New +$660K
TRVN
370
DELISTED
Trevena, Inc.
TRVN
$660K 0.1%
+128
New +$645K
GEN
371
DELISTED
Genesis Healthcare, Inc.
GEN
$660K 0.1%
284,386
-51,260
-15% -$116K
WMAR
372
DELISTED
West Marine Inc
WMAR
$658K 0.09%
+72,346
New +$619K
SCS
373
DELISTED
Steelcase
SCS
$656K 0.09%
43,955
-181,514
-81% -$2.41M
CVI icon
374
CVR Energy
CVI
$3.43B
$651K 0.09%
+24,927
New +$727K
DATA
375
DELISTED
Tableau Software, Inc.
DATA
$651K 0.09%
+14,195
New +$824K
13 14
15
16 17

Similar funds

KC
KRV Capital New York $255M AUM 18.27% 1-Year Est. Return
IPC
Independent Portfolio Consultants Boca Raton, Florida $241M AUM 21.8% 1-Year Est. Return
ECPI
Energy Capital Partners III Summit, New Jersey $237M AUM
FRM
Fore Research & Management New York $221M AUM 2.93% 1-Year Est. Return
WFG
Windsor Financial Group Minneapolis, Minnesota $214M AUM 6.66% 1-Year Est. Return
IFB
iAB Financial Bank Fort Wayne, Indiana $204M AUM 19.19% 1-Year Est. Return
KL
Kinsight LLC Birmingham, Alabama $176M AUM 17.21% 1-Year Est. Return
RP
Ridgegate Proprietary Sydney, Australia $154M AUM 25.47% 1-Year Est. Return

TFS Capital's Q1 2016 Portfolio in Review

As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.

TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.

Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.

  • TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
  • TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
  • TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
  • TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
  • TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
  • TFS Capital opened 502 new positions and closed 257 in Q1 2016.
  • TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.

Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.